NUVB.WS icon

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50

19 hedge funds and large institutions have $2.26M invested in Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
EC
1
EcoR1 Capital
California
$1.73M 963,333
6CM
2
683 Capital Management
New York
$138K 835,323
Franklin Resources
3
Franklin Resources
California
$44.1K 266,666
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$44.1K 266,666
BC
5
Boxer Capital
California
$44K 266,666
HCM
6
Highbridge Capital Management
New York
CCA
7
Castle Creek Arbitrage
Colorado
$32.9K 215,426
DM
8
Deerfield Management
New York
$27.6K 166,666
BlackRock
9
BlackRock
New York
$25.4K 153,756 -2,146 -1%
RSCM
10
Rock Springs Capital Management
Maryland
$22.2K 134,028
SB
11
Samsara BioCapital
California
$22.1K 133,333
GC
12
Greenlight Capital
New York
$16.5K 100,000
ACP
13
Acuta Capital Partners
California
$15K 90,832
APM
14
Avidity Partners Management
Texas
$15K 90,560 -9,439 -9%
Citadel Advisors
15
Citadel Advisors
Florida
$12.1K 73,358 -1,700 -2%
LGM
16
Logos Global Management
California
$11K 66,666
Victory Capital Management
17
Victory Capital Management
Texas
$10.2K 61,731
CC
18
Clearline Capital
New York
$5.5K 33,271
IP
19
Intellectus Partners
California
$1.8K 10,891 +10,891 New
Barclays
20
Barclays
United Kingdom
$0 1,638
CFGS
21
Concourse Financial Group Securities
Alabama